BFC Planning, Inc.’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.06M Buy
127,112
+2,467
+2% +$64.5K 0.12% 172
2026
Q1
$3.5M Buy
124,645
+1,766
+1% +$47K 0.16% 134
2025
Q4
$3.06M Buy
122,879
+69,065
+128% +$1.74M 0.14% 150
2025
Q3
$1.37M Sell
53,814
-1,113
-2% -$27.5K 0.1% 185
2025
Q2
$1.33M Sell
54,927
-4,404
-7% -$103K 0.1% 180
2025
Q1
$1.5M Buy
59,331
+26
+0% +$680 0.13% 154
2024
Q4
$1.57M Buy
+59,305
New +$1.61M 0.13% 142

Other funds holding PFE

BFC Planning, Inc.'s PFE Position: Q2 2026 in Review

BFC Planning, Inc. increased its Pfizer (PFE) stake by 2% in Q2 2026, buying an estimated $64.5K and bringing the position to 127,112 shares worth $3.06M. The position accounts for 0.12% of the portfolio, ranked #172.

BFC Planning, Inc. first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.5M in Q1 2026. 2,854 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • BFC Planning, Inc. held 127,112 shares of Pfizer worth $3.06M as of Q2 2026.
  • BFC Planning, Inc. bought 2,467 Pfizer shares in Q2 2026, an estimated $64.5K.
  • Pfizer made up 0.12% of BFC Planning, Inc.'s portfolio in Q2 2026, its #172 holding.
  • BFC Planning, Inc. first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • BFC Planning, Inc.'s Pfizer position peaked at $3.5M in Q1 2026.
  • 2,854 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.